Filed with ASX · · 2 pages · English
Rhythm Biosciences Limited announced that its ColoSTAT® test can now be ordered through major GP software platforms used by most Australian practices, enhancing accessibility for patients. Rhythm's focus is now on promoting the routine use of ColoSTAT® among GPs to improve early detection of colorectal cancer.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
ASX Announcement 5 November 2026 ColoSTAT® now orderable in GP software used by an estimated 95% of Australian practices; 130+ collection sites live Highlights ? GPs using Best Practice Premier (Bp Premier) can order ColoSTAT® from within their clinical software immediately. ? With...
Rhythm Biosciences Limited on 6ix
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences